Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,633,992)	$ (1,904,166)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	3,118	1,484
Accrued stock compensation to employees	2,470	7,300
Accrued stock compensation to non-employees	4,750	24,090
Increase or decrease in:
Accounts receivable	(25,394)	5,248
Inventory	13,859	3,278
Prepaid clinical expenses	59,096
Prepaid insurance and services	(37,013)
Other current assets	(9,615)	(28,716)
Other	226	460
Accounts payable and accrued expenses	803,630	665,789
Total adjustments	824,742	678,933
NET CASH USED IN OPERATING ACTIVITIES	(1,809,250)	(1,225,233)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of furniture and equipment	(50,627)	(1,324)
Proceeds from mortgage note receivable	9,615	9,216
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	(41,012)	7,892
CASH FLOWS FROM FINANCING ACTIVITIES
Collection of stock subscription receivable		130,062
Other		(15,000)
NET CASH PROVIDED BY FINANCING ACTIVITIES		115,062
NET DECREASE IN CASH AND CASH EQUIVALENTS	(1,850,262)	(1,102,279)
CASH AND CASH EQUIVALENTS, beginning of period	2,783,719	2,217,412
CASH AND CASH EQUIVALENTS, end of period	933,457	1,115,133
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Capitalization of right-to-use asset and lease liability		$ 64,231